Skip to main content

2025 IDWeek Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

Ernest Asante-Appiah, PhD

Merck & Co,. Inc

Disclosure(s): Merck & Co. Inc: Employee, Stocks/Bonds (Private Company)

Poster(s):

(P-389) Switching to Doravirine/Islatravir (100 mg/0.25 mg) Once Daily Maintains Viral Suppression Through Week 48 in the Presence of Archived NNRTI Resistance-Associated Mutations or M184I/V in Proviral DNA

Monday, October 20, 2025
12:15 PM - 1:30 PM US ET